Trends in time to confirmation and recognition of new-onset hypertension, 2002-2006

Hypertension

Volumn 56, Issue 4, 2010, Pages 605-611

  Selby, Joe V ^a   Lee, Janelle ^a   Swain, Bix E ^a   Tavel, Heather M ^b   Ho, P Michael ^c,d   Margolis, Karen L ^e   Oconnor, Patrick J ^e   Fine, Lawrence ^f   Schmittdiel, Julie A ^a   Magid, David J ^b  

^a DIVISION OF RESEARCH   (United States)

^b KAISER PERMANENTE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

early detection; electronic health records; hypertension; registries; screening

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREND STUDY;

AGE OF ONSET; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CALIFORNIA; COLORADO; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGISTRIES; TIME FACTORS;

EID: 77957238170     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.153528     Document Type: Article

References (26)

1. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-2997.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Hypertension. 2003;42:1206-1252. (Pubitemid 37553153)
3. Eddy DM, Pawlson LG, Schaaf D, Peskin B, Shcheprov A, Dziuba J, Bowman J, Eng B. The potential effects of HEDIS performance measures on the quality of care. Health Aff (Millwood). 2008;27:1429-1441.
4. Steinberg BA, Bhatt DL, Mehta S, Poole-Wilson PA, OHagan P, Montalescot G, Ballantyne CM, Cannon CP. Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease. Am Heart J. 2008;156:719-727.
5. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008;52:818-827.
6. McWilliams JM, Meara E, Zaslavsky AM, Ayanian JZ. Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of medicare coverage. Ann Intern Med. 2009;150:505-515.
7. Rosner B, Polk BF. The implications of blood pressure variability for clinical and screening purposes. J Chronic Dis. 1979;32:451-461. (Pubitemid 9253378)
8. Keenan K, Hayen A, Neal BC, Irwig L. Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial. BMJ. 2009;338:b1492.
9. Kerr EA, Zikmund-Fisher BJ, Klamerus ML, Subramanian U, Hogan MM, Hofer TP. The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure. Ann Intern Med. 2008;148:717-727. (Pubitemid 351717417)
10. Selby JV, Peng T, Karter AJ. High rates of co-occurrence of hypertension, elevated low-density lipoprotein cholesterol, and diabetes mellitus in a large managed care population. Am J Manag Care. 2004; 10:163-170. (Pubitemid 38332390)
11. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F; Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247-254. (Pubitemid 46768608)
12. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, Moskowitz MA. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957-1963. (Pubitemid 29024127)
13. Hyman D, Pavlik V. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000;160:2281-2286.
14. Oliveria S, Lapuerta P, McCarthy B, LItalien G, Berlowitz DR, Asch S. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413-420. (Pubitemid 34150642)
15. Asch SM, McGlynn EA, Hiatt L, Adams J, Hicks J, DeCristofaro A, chen R, LaPuerta P, Kerr EA. Quality of care for hypertension in the United States. BMC Cardiovasc Disord. 2005;5:1-9. (Pubitemid 40190552)
16. Rodondi N, Peng T, Karter AJ, Bauer DC, Vittinghoff E, Tang S, Pettitt D, Kerr EA, Selby JV. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med. 2006;144:475-484. (Pubitemid 46780670)
17. Traylor A, Subramanian U, Uratsu CS, Mangione CM, Selby JV, Schmittdiel JA. Patient race/ethnicity and patient-physician race/ethnicity concordance in the management of CVD risk factors for patients with diabetes. Diabetes Care. 2010;33:520-525.
18. Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P; Task Force V. Whitecoat hypertension. Blood Press Monit. 1999;4:333-341.
19. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47:846-853. (Pubitemid 44297554)
20. Staessen JA, Thijs L, Fagard R, OBrien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J; for the Systolic Hypertension in Europe Trial Investigators. Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. JAMA. 1999;282:539-546. (Pubitemid 29380290)
21. Banegas JR, Segura J, Sobrino J, Rodríguez-Artalejo F, de la Sierra A, de la Cruz JJ, Gorostidi M, Sarría A, Ruilope LM; for the Spanish Society of Hypertension Ambulatory Blood Pressure Monitoring Registry Investigators. Effectiveness of blood pressure control outside the medical setting. Hypertension. 2007;49:62-68. (Pubitemid 46360342)
22. Bibbins-Domingo K, Pletcher MJ, Lin F, Vittinghoff E, Gardin JM, Arynchyn A, Lewis CE, Williams OD, Hulley SB. Racial differences in incident heart failure among young adults. N Engl J Med. 2009;360: 1179-1190.
23. Sierra C, de la Sierra A. Early detection and management of the high-risk patient with elevated blood pressure. Vasc Health Risk Manag. 2008;4: 289-296. (Pubitemid 351711957)
24. Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet. 2010;375:895-905.
25. Igho-Pemu P, Quarshie A, Oduwole A, Lapu-Bula R, Mayberry R, Obialo C, Gibbons GH, Ofili E. Morehouse Community Physicians Network (CPN) hypertension registry: patterns of care and opportunities for targeted medical education. Ethn Dis. 2005;15(suppl):S5-120-123. (Pubitemid 41824445)
26. Ferrari P, Kim SK, Wu CJ, Pham NV, Ageev F, Hermosillo LD, Esper R; for the RIAT Trialists. Aim, design and methods of the reasons for not intensifying antihypertensive treatment (RIAT): an international registry in essential hypertension. J Hum Hypertens. 2006;20:31-36.